The American Herbal Products Association (AHPA; Silver Spring, MD) recently conducted a survey to determine what percentage of its membership is in favor of AHPA supporting a requirement for all dietary supplements in the U.S. to be listed in a federal database.
Given recent developments in the CBD space, what does the future hold for hemp-derived CBD and other cannabinoids?
MacKay, a doctor of naturopathic medicine, most recently served as senior vice president, scientific and regulatory affairs at CV Sciences.
NNB Nutrition’s MitoBurn, a non-protein amino acid metabolite of the branched-chain amino acid L-valine, is now self-affirmed GRAS as a powdered food ingredient in sports drinks and in grain-based bars, nutrition bars, and instant-powdered nutritional beverages.
Health Canada recognizes a probiotic from Lallemand Health Solutions for the support of a healthy vaginal microbiome.
New bill to expand HSA and FSA coverage to include dietary supplements as a medical expense.
FDA and FTC sent warning letters to ten companies.
More labeling transparency, strain specificity, and research is needed to strengthen the evidence linking probiotics with health benefits, said two experts at the Consumer Healthcare Products Association’s Regulatory, Scientific & Quality Conference last week.
Legislation could very well be in the works to propose mandatory product listing for dietary supplements in the U.S., said speakers at the Consumer Healthcare Products Association’s Regulatory, Scientific & Quality Conference last week.
NattoPharma has secured patents in Canada and South Korea for its proprietary process of synthesizing MenaQ7 PharmaPure Vitamin K2.
Bionap Bioactive Natural Products has achieved self-GRAS status with the help of GRAS Associates, a fully-owned subsidiary of Nutrasource.
AHPA submits comments to the Senate sponsoring office of the "Cannabis Administration and Opportunity Act."
Matt Storey of NuSachi Inc. discusses the challenges of establishing cannabis evidence to satisfy both regulators and consumers alike.
The company's Astaferm astaxanthin for soft-gels is now self-affirmed GRAS.
AIDP granted NPN from Health Canada for BeautyOLIGO, a galacto-oligosaccharides prebiotic.
TSI Group's myHMB receives ANVISA approval in Brazil.
A trademark application has been withdrawn for the word "herbalist" after a coordinated industry effort.
The new patent is for L-ergothioneine's support of eye health.
NPA files citizen petition for FDA to reverse its position that N-acetyl-L-cysteine cannot be marketed as a dietary supplement.
Katie Fillinger of NSF International’s Health Sciences Certification program explains some possible cGMP certification pathways.
CHPA announces speakers and agenda for its 2021 Regulatory, Scientific & Quality Conference
The GRAS notification covers all steviol glycosides extracted from the stevia leaf, broadening SoPure’s authorized usage status to include its entire stevia portfolio.
Sweegen says it is the first company to receive the European Food Safety Authority (EFSA) panel’s safety status for any steviol glycoside “produced by alternative and sustainable technologies.”
Nutriterra Total Omega-3 Canola Oil is “the world’s first plant-based source of long-chain omega-3 fatty acids,” the company claims, as it combines omega-3 fatty acids DHA, EPA, and alpha-linolenic acid (ALA).
What can U.S. companies do now to prepare if CBD is legalized for dietary supplements? An expert advises.
Leading CBD companies Charlotte’s Web and Irwin Naturals submitted NDI notifications for full-spectrum hemp extracts. FDA objected to the notifications on the grounds of the drug-exclusion clause and the agency’s concern about safety substantiation.
Upgrades were made to modernize the site and make it easier for users to find and share dietary supplement information.
In June 2021, dietary supplements company NOW purchased from Amazon.com 23 non-NOW turmeric/curcumin supplement products, plus two of its own supplement products, and tested them for potency, heavy metals, labeling accuracy, and potential addition of synthetic curcumin.
The first NPN is for the company’s BacoMind Children ingredient, and the second NPN is for the company’s BacoMind Adult ingredient.
How can you market pain-relief dietary supplements while staying on the right side of legally permissible health claims?
